Douglas Wayne Axelrod

Title: Innovations of Douglas Wayne Axelrod

Introduction

Douglas Wayne Axelrod is a notable inventor based in Norwich, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 4 patents to his name, Axelrod's work focuses on improving the delivery and efficacy of active ingredients in medications.

Latest Patents

One of Axelrod's latest patents is centered around dosage forms of risedronate. This invention presents a novel enteric-coated oral dosage form that includes a safe and effective amount of a pharmaceutical composition. The formulation is designed to protect the risedronate active ingredient from exposure to the epithelial and mucosal tissues of the buccal cavity, pharynx, esophagus, and stomach. By doing so, it aims to prevent erosion, ulceration, or irritation of these tissues. The dosage forms are intended to effectively deliver the risedronate active ingredient to the lower intestinal tract, thereby alleviating esophagitis or esophageal irritation that can occur with oral administration.

Career Highlights

Axelrod is currently associated with The Procter & Gamble Company, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the safety and effectiveness of medication delivery systems.

Collaborations

Throughout his career, Axelrod has collaborated with notable colleagues, including Richard John Dansereau and Russell Youker Mosher. These partnerships have contributed to the development of his innovative ideas and patents.

Conclusion

Douglas Wayne Axelrod's contributions to pharmaceutical innovations, particularly in the area of risedronate dosage forms, highlight his commitment to improving patient care. His work continues to influence the field and showcases the importance of innovation in medicine.